4//SEC Filing
Bunker Kevin D. 4
Accession 0001725160-23-000020
CIK 0001725160other
Filed
Jan 31, 7:00 PM ET
Accepted
Feb 1, 7:09 PM ET
Size
10.6 KB
Accession
0001725160-23-000020
Insider Transaction Report
Form 4
Bunker Kevin D.
Chief Operating Officer
Transactions
- Gift
Common Stock
2022-11-09−30,000→ 784,110 total - Award
Stock Option (Right to Buy)
2023-02-01+132,646→ 132,646 totalExercise: $23.65Exp: 2033-01-31→ Common Stock (132,646 underlying) - Award
Common Stock
2023-02-01+91,354→ 875,464 total
Holdings
- 350(indirect: As UTMA custodian for sons)
Common Stock
- 95,000(indirect: See Footnote)
Common Stock
Footnotes (3)
- [F1]Represents restricted stock units, each of which represent a contingent right to receive one share of common stock, and which will vest in substantially equal annual installments over a four year period following the grant date.
- [F2]Represents shares nominally held by Sundog Ranch, Inc. on behalf of the Bunker Family Protection Trust, the sole shareholder of Sundog Ranch, Inc. The Reporting Person and his wife are the primary beneficiaries of the Bunker Family Protection Trust and the Reporting Person and his wife are also directors of Sundog Ranch, Inc. The Reporting Person disclaims beneficial ownership of the securities held by Sundog Ranch, Inc. except to the extent of his pecuniary interest therein, if any.
- [F3]The option vests and becomes exercisable in 48 substantially equal monthly installments following the grant date.
Documents
Issuer
Zentalis Pharmaceuticals, Inc.
CIK 0001725160
Entity typeother
Related Parties
1- filerCIK 0001807484
Filing Metadata
- Form type
- 4
- Filed
- Jan 31, 7:00 PM ET
- Accepted
- Feb 1, 7:09 PM ET
- Size
- 10.6 KB